QE

Qiaojing Eastern Investment

Description

Qiaojing Eastern Investment operates as an investment firm.

Investor Profile

Qiaojing Eastern Investment has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series C rounds (top funding stages).
  • Majority of deals are located in China.
  • Strong thematic focus on Biotechnology, Health Care, Oncology.

Stage Focus

  • Series C (100%)

Country Focus

  • China (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Oncology
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Qiaojing Eastern Investment frequently co-invest with?

Lake Bleu Capital
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 1
Growth Capital Partners
Europe, England, United Kingdom, London
Co-Investments: 1
Huagai Capital
Asia, Beijing, China, Beijing
Co-Investments: 1
Baidu Ventures
Asia, Beijing, China, Beijing
Co-Investments: 1
CDH Investments
Asia, Kowloon, Hong Kong, Kowloon City
Co-Investments: 1
HM Capital
North America, Texas, United States, Dallas
Co-Investments: 1
Dyee Capital
Asia, Fujian, China, Xiamen
Co-Investments: 1
Pan-Lin Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 1
CHERAMI
Asia, Guangdong, China, Guangzhou
Co-Investments: 1
ABC International
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 1

What are some of recent deals done by Qiaojing Eastern Investment?

GenFleet Therapeutics

Shanghai, Shanghai, China

GenFleet Therapeutics is a biotechnology developer and researcher of molecular pharmaceuticals targeting cancer treatments.

BiotechnologyHealth CareOncologyPharmaceutical
Series CDec 31, 2021
Amount Raised: $78,667,065